About
Biologics including a customized variant of interleukin-18
Areas of Focus
Categories
Biologics & BiopharmaceuticalBoston & New England
Team (14)
Aaron Ring
Aaron Ring, M.D., Ph.D.
Simcha Therapeutics
team_member
Axel Hoos
Axel Hoos, M.D., Ph.D.
Simcha Therapeutics
team_member
Beatrice McQueen
Beatrice McQueen, Ph.D.
Simcha Therapeutics
team_member
Emmett Schmidt
Emmett Schmidt, M.D., Ph.D.
Simcha Therapeutics
team_member
Hirdesh Uppal
Hirdesh Uppal, Ph.D.
Simcha Therapeutics
team_member
Jake Bauer
Jake Bauer
Simcha Therapeutics
team_member
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
0
As Collaborator
3
Total Enrollment
54
By Phase
PHASE1/PHASE2: 1PHASE1: 2
By Status
RECRUITING: 2TERMINATED: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
2040
2041
2042
2043
2044
Today
Hover over trial bars to see details
Recent Trials
NCT07098364Collaborator
ST-067 in Combination With CD19-Directed CAR T-Cell Therapy (Liso-cel) in Relapsed/Refractory Large B-Cell Lymphoma
PHASE1/PHASE2Recruiting
33 participants
Started: Nov 1, 2025 · Completed: Oct 4, 2043
NCT06588660Collaborator
ST-067 and Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma
PHASE1Terminated
1 participants
Started: Dec 18, 2024 · Completed: Feb 14, 2025
NCT06492707Collaborator
DR-18 for the Treatment of Relapsed or Persistent Acute Myeloid Leukemia or Myelodysplastic Syndrome After Hematopoietic Cell Transplantation, the DR. DREAM Trial
PHASE1Recruiting
20 participants
Started: Sep 23, 2024 · Completed: Oct 1, 2027
Locations (1)
Headquarters
New Haven, CT, United States
Map
Loading map...